Bone cancer survivor now relieves others ’ pain as orthopedic surgeon
For then-high school freshman Kevin Weiss, the pain in his knee started while doing something he loved — playing basketball. By spring, the pain he had while sprinting at track practice became too severe for this multi-sport athlete to ignore.
After a trip to the doctor’s office and a subsequent X-ray, 15-year-old Weiss was diagnosed with osteosarcoma, one of the most common types of bone cancer , which tends to occur in children and teens.
Osteosarcoma is also a fast-growing cancer that is… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 1, 2021 Category: Biotechnology Authors: Atrium Health Source Type: news
Bone cancer survivor now relieves others ’ pain as orthopedic surgeon
For then-high school freshman Kevin Weiss, the pain in his knee started while doing something he loved — playing basketball. By spring, the pain he had while sprinting at track practice became too severe for this multi-sport athlete to ignore.
After a trip to the doctor’s office and a subsequent X-ray, 15-year-old Weiss was diagnosed with osteosarcoma, one of the most common types of bone cancer , which tends to occur in children and teens.
Osteosarcoma is also a fast-growing cancer that is… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 1, 2021 Category: Pharmaceuticals Authors: Atrium Health Source Type: news
Predictors of Survival After Osteosarcoma
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - January 27, 2021 Category: Orthopaedics Tags: Trends and Innovations Source Type: news
Nixing bone cancer fuel supply offers new treatment approach, mouse study suggests
(Washington University School of Medicine) An innovative approach to treating bone tumors - starving cancer cells of the energy they need to grow - could one day provide an alternative to a commonly used chemotherapy drug without the risk of severe side effects, suggests a new study from Washington University School of Medicine in St. Louis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 26, 2021 Category: Cancer & Oncology Source Type: news
What Is the Survival Rate of Ewing Sarcoma
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 30, 2020 Category: General Medicine Source Type: news
It Happens Here: Marshfield ’ s Magical Moon Farm Needs Your Help
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p0").init({"mcp":"cbs","width":"100%","height":"100%","video":"4916325","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p0","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId":"sc_va","marketingCloudId":"823BA0335567497F7F000101@AdobeOrg","trackingServer":"cbsdigitalmedia.hb.omtrdc.net","customTrackingServer":"cbsdigitalmedia.d1.sc.omtrdc.net","chapterTracking":false,"version":"1.5"},"comscore":{"clientId"...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 30, 2020 Category: Consumer Health News Authors: CBS Boston Tags: Boston News Syndicated Local It Happens Here Magical Moon Farm Marshfield News Source Type: news
How Common Are Bone Spurs in Young Athletes?
Discussion
The terminology of abnormal calcification of soft tissues and uses of the terms is often muddied. Especially as the causes may be similar and multiple adjacent tissues may be involved.
An exostosis is an abnormal proliferation of bone from the joint. They can appear in various forms and in many locations.
An osteophyte is also known as a bone spur and is type of exostosis. Osteophytes are thought to be periosteal or synovial mesenchymal stems cells that become calcified. They usually have a more narrow or pointed projection from the joint. Osteophytes are a very common feature of osteoarthritis.
Enthesophytes a...
Source: PediatricEducation.org - November 30, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
What Causes Joint Pain?
DiscussionMusculoskeletal problems are common problems in pediatric practice with up to 15% of acute care visits being for this problem.
Joint pain is a common concern for families but the differential diagnosis is extensive and needs thoughtful consideration. History is a key to discerning the potential diagnosis but also in guiding the physical examination and laboratory examination. Family history especially for systemic diseases should be considered. On physical examination all joints should be examined include sacroiliac and temporomandibular joints.
Is this arthritis or arthralgia? Distinction between inflammatory...
Source: PediatricEducation.org - October 26, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Researchers uncover crucial gene for growth of Ewing sarcoma
(Center for Genomic Regulation) Researchers have discovered a gene that is critical for the development of Ewing sarcoma, a rare type of developmental cancer that presents in bones and soft tissues. Exploring the pharmacological inhibition of RING1B as a clinical therapy to treat Ewing sarcoma could open the door for new treatments for the rare disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 23, 2020 Category: Cancer & Oncology Source Type: news
UT Health San Antonio researcher, Scottish colleague, receive grant to study Ewing sarcoma
(University of Texas Health Science Center at San Antonio) While COVID-19 has become the top health priority around the world, a child is still diagnosed with cancer every two minutes globally. To meet the continuing need for pediatric cancer treatments, Alexander Bishop, DPhil, from The University of Texas Health San Antonio and Professor Kevin Hiom at the University of Dundee, Scotland, are teaming up to investigate a unique biological hallmark of Ewing sarcoma, R-loops. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 19, 2020 Category: Cancer & Oncology Source Type: news
The CNIO reprograms CRISPR system in mice to eliminate tumor cells without affecting healthy cells
(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) CNIO researchers destroyed Ewing's sarcoma and chronic myeloid leukaemia tumor cells by using CRISPR to cut out the fusion genes that cause them. For the first time, fusion genes have been selectively and efficiently removed using CRISPR. These genes are attracting a great deal of interest from the research community because they are unique to the tumor cell and are therefore excellent targets for the development of future drugs that only attack the tumor and are harmless for healthy cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 8, 2020 Category: Cancer & Oncology Source Type: news
Oncotarget: Exosomes secreted under hypoxia enhance stemness in Ewing's sarcoma
(Impact Journals LLC) The cover for issue 40 of Oncotarget features Figure 5, " miR-210 silences the proapoptosis member CASP8AP2, " by Kling, et al. which reported that hypoxic Ewing's sarcoma cells release exosomes that promote sphere formation, a stem-like phenotype, in EWS cells by enhancing survival. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 8, 2020 Category: Cancer & Oncology Source Type: news
New osteosarcoma treatment receives rare pediatric disease designation from the FDA
(Medical University of South Carolina) Innova Therapeutics Inc. recently announced that the U.S. Food and Drug Administration has granted rare pediatric disease designation for IVT-8086 for the treatment of osteosarcoma. MUSC Hollings Cancer Center researcher Nancy Klauber-DeMore, M.D., was instrumental in the development of the research that led to the therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 2, 2020 Category: Cancer & Oncology Source Type: news
Woman receives successful treatment for rare cancer in Charlotte
Jo Ellen Marrow was diagnosed with a rare tissue cancer called sarcoma in March 2020. She went to Levine Cancer Institute, ranked nationally by U.S. News& World Report, for treatments. Using a mixture of both virtual and in-person care due to COVID-19, she was able to receive treatment to achieve a successful recovery.
Learn more about the sarcoma and bone cancer program at Levine Cancer Institute. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 1, 2020 Category: Biotechnology Authors: Atrium Health Source Type: news
Researchers use soy to improve bone cancer treatment
(Washington State University) Researchers showed that the slow release of soy-based chemical compounds from a 3D-printed bone-like scaffold resulted in a reduction in bone cancer cells while building up healthy cells and reducing harmful inflammation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 15, 2020 Category: Cancer & Oncology Source Type: news
